Search
for
Sort by
Research 30 of 1000+
- Off-label dermatologic uses of IL-23 inhibitors
- Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors: A Clinical Review of Reaction Patterns
- Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review
- Hair Loss Associated With IL ‐17 and IL ‐23 Inhibitors: A Systematic Review
- A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- The effect of 5-α reductase inhibitor on Th1, Th2, and Th17 cell-related inflammatory response in BPH
- TNF-α Inhibitor-Induced Psoriasis and Psoriatic Alopecia in Adolescent with Ulcerative Colitis: Clinical Case
- Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Paradoxical reactions in the era of modern biological therapy of psoriasis — a comprehensive analysis of pathomechanisms and clinical guidelines
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- 224 Humoral immune response to COVID-19 vaccination in psoriasis patients on biologic therapy is impaired compared to healthy controls
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Cytostatics and immunosuppressive drugs
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Alopecia Areata: A Complex Cytokine Driven Disease
- Current and future pharmacotherapy for alopecia areata
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
- Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease
- Psoriatic Alopecia: Clinical Features, Pathogenesis, and Emerging Treatment Strategies
- 314 Molecular genetic dissection of ILVEN leads to successful targeted therapy
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- Emerging treatments in alopecia